1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 45, 07/Nov/2024
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

Circulating type 3 vaccine-derived polioviruses (cVDPV3s) were detected in three wastewater samples collected in French Guiana from May through August 2024. As the oral polio vaccine is not used in French Guiana, this event involved an import either of cVDPV3s themselves or of a vaccine strain from which the cVDPV3s emerged in French Guiana. This highlights the importance of environmental surveillance for the detection of silent poliovirus circulation. Eliminating any pockets of cVDPVs is crucial for the polio eradication programme.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.45.2400705
2024-11-07
2024-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.45.2400705
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/45/eurosurv-29-45-2.html?itemId=/content/10.2807/1560-7917.ES.2024.29.45.2400705&mimeType=html&fmt=ahah

References

  1. Journal officiel de la République française. Décret n° 2018-42 du 25 janvier 2018 relatif à la vaccination obligatoire. [Decree on mandatory vaccination]. Paris: Journal officiel de la République française; 2018. French. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000036543886
  2. Ministère des Affaires sociales et de l’Emploi. Bulletin épidémiologique hebdomadaire n°6/1987. [Weekly epidemiological bulletin]. Paris: Direction générale de la Santé; 1987. French. Available from: https://beh.santepubliquefrance.fr/beh/1987/06/beh_06_1987.pdf
  3. Haut Conseil de la santé publique. Conduite à tenir autour d’un cas de poliomyélite ou lors de la détection de poliovirus. Rapport du Haut Conseil de la santé publique. [Guidance for the response to a poliomyelitis case or a detection of poliovirus]. Paris: Haut Conseil de la santé publique. [Accessed: 24 Oct 2024]. French. Available from: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=750
  4. Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C, et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022;400(10362):1531-8.  https://doi.org/10.1016/S0140-6736(22)01804-9  PMID: 36243024 
  5. World Health Organization (WHO). Guidelines for environmental surveillance of poliovirus circulation. Geneva: WHO; 2003. Available from: https://polioeradication.org/wp-content/uploads/2016/07/WHO_V-B_03.03_eng.pdf
  6. Thorley BR, Roberts JA. Isolation and Characterization of Poliovirus in Cell Culture Systems. Methods Mol Biol. 2016;1387:29-53.  https://doi.org/10.1007/978-1-4939-3292-4_4  PMID: 26983730 
  7. Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al. Diagnostic assay development for poliovirus eradication. J Clin Microbiol. 2018;56(2):e01624-17.  https://doi.org/10.1128/JCM.01624-17  PMID: 29212703 
  8. Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM. Molecular properties of poliovirus isolates: nucleotide sequence analysis, typing by PCR and real-time RT-PCR. Methods Mol Biol. 2016;1387:177-212.  https://doi.org/10.1007/978-1-4939-3292-4_9  PMID: 26983735 
  9. Global Polio Eradication Initiative. Classification and reporting of vaccine-derived polioviruses (VDPV). Geneva: Global Polio Eradication Initiative; 2016. Available from: https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf
  10. Combelas N, Holmblat B, Joffret ML, Colbère-Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses. 2011;3(8):1460-84.  https://doi.org/10.3390/v3081460  PMID: 21994791 
  11. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59(1):587-635.  https://doi.org/10.1146/annurev.micro.58.030603.123625  PMID: 16153180 
  12. Agence régionale de santé Guyane. ARS newsletter. Cayenne: Agence régionale de santé Guyane; 2024. Available from: https://eye.newsletter.ars.sante.fr/m2?r=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
  13. Geiger K, Stehling-Ariza T, Bigouette JP, Bennett SD, Burns CC, Quddus A, et al. Progress toward poliomyelitis eradication - worldwide, January 2022-December 2023. MMWR Morb Mortal Wkly Rep. 2024;73(19):441-6.  https://doi.org/10.15585/mmwr.mm7319a4  PMID: 38753550 
  14. Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283-93.  https://doi.org/10.1093/infdis/jiu295  PMID: 25316847 
  15. Mohanty A, Rohilla R, Zaman K, Hada V, Dhakal S, Shah A, et al. Vaccine derived poliovirus (VDPV). Infez Med. 2023;31(2):174-85. PMID: 37283637 
  16. Raharinantoanina J, Joffret ML, Bessaud M, Rakoto DAD, Dussart P, Lacoste V, et al. Wide circulation of type 1 vaccine-derived poliovirus strains in clinical specimens from suspected cases of poliomyelitis, their contacts and in wastewater in Madagascar since late 2020. Virology. 2024;600:110253.  https://doi.org/10.1016/j.virol.2024.110253  PMID: 39357254 
  17. Oduoye MO, Ubechu SC, Mourid MR, Ahmad AI, Adegoke AA, Arama UO, et al. Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences. New Microbes New Infect. 2024;62:101489.  https://doi.org/10.1016/j.nmni.2024.101489  PMID: 39381618 
  18. Weil M, Sofer D, Shulman LM, Weiss L, Levi N, Aguvaev I, et al. Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. Sci Total Environ. 2023;871:161985.  https://doi.org/10.1016/j.scitotenv.2023.161985  PMID: 36739034 
  19. Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol. 2008;82(9):4429-40.  https://doi.org/10.1128/JVI.02354-07  PMID: 18287242 
  20. Nacher M, Epelboin L, Bonifay T, Djossou F, Blaizot R, Couppié P, et al. Migration in French Guiana: Implications in health and infectious diseases. Travel Med Infect Dis. 2024;57:102677.  https://doi.org/10.1016/j.tmaid.2023.102677  PMID: 38049022 
  21. Breton D, Marie CV, Floury E, Crouzet M, Lottin A, Taupe G, et al. Migrations, Famille et Vieillissement en Guyane. Institut national d’études démographiques. [Migration, family and ageing in French Guina]. Aubervilliers: Institut national d’études démographiques; 2023. French. Available from: https://www.ined.fr/fichier/s_rubrique/34297/brochure_mfv_guyane_04.12.fr.pdf
  22. Kasstan B, Mounier-Jack S, Chantler T, Masters N, Flores SA, Stokley S, et al. Poliovirus outbreak in New York State, August 2022: qualitative assessment of immediate public health responses and priorities for improving vaccine coverage. Epidemiol Infect. 2023;151:e120.  https://doi.org/10.1017/S0950268823001127  PMID: 37435800 
  23. Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, et al. Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. Euro Surveill. 2022;27(37):2200694.  https://doi.org/10.2807/1560-7917.ES.2022.27.37.2200694  PMID: 36111556 
  24. Bandyopadhyay AS, Lopez Cavestany R, Blake IM, Macklin G, Cooper L, Grassly N, et al. Use of inactivated poliovirus vaccine for poliovirus outbreak response. Lancet Infect Dis. 2024;24(5):e328-42.  https://doi.org/10.1016/S1473-3099(23)00505-4  PMID: 38012892 
  25. Shulman LM, Martin J, Sofer D, Burns CC, Manor Y, Hindiyeh M, et al. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013. Clin Infect Dis. 2015;60(7):1057-64.  https://doi.org/10.1093/cid/ciu1136  PMID: 25550350 
  26. Kishore N, Krow-Lucal E, Diop OM, Jorba J, Avagnan T, Grabovac V, et al. Surveillance to track progress toward polio eradication - worldwide, 2022-2023. MMWR Morb Mortal Wkly Rep. 2024;73(13):278-85.  https://doi.org/10.15585/mmwr.mm7313a1  PMID: 38573841 
  27. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547-9.  https://doi.org/10.1093/molbev/msy096  PMID: 29722887 
Detection of circulating type 3 vaccine-derived polioviruses in French Guiana, May to August 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=St%C3%A9phanie+Raffestin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Raffestin Stéphanie</a>, <a href="/search?value1=Ambre+Tinard&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tinard Ambre</a>, <a href="/search?value1=Antoine+Enfissi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Enfissi Antoine</a>, <a href="/search?value1=Marie-Line+Joffret&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Joffret Marie-Line</a>, <a href="/search?value1=Timoth%C3%A9e+Lichtenstein&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lichtenstein Timothée</a>, <a href="/search?value1=Sourakhata+Tirera&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tirera Sourakhata</a>, <a href="/search?value1=Laura+Zanetti&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zanetti Laura</a>, <a href="/search?value1=Marie+Barrau&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Barrau Marie</a>, <a href="/search?value1=Francky+Mubenga&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mubenga Francky</a>, <a href="/search?value1=Adrien+Ortelli&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ortelli Adrien</a>, <a href="/search?value1=Christophe+N+Peyrefitte&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Peyrefitte Christophe N</a>, <a href="/search?value1=Anne+Lavergne&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lavergne Anne</a>, <a href="/search?value1=Dominique+Rousset&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rousset Dominique</a>, <a href="/search?value1=Ma%C3%ABl+Bessaud&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bessaud Maël</a></span>. Detection of circulating type 3 vaccine-derived polioviruses in French Guiana, May to August 2024. <a href="/content/ecdc">Euro Surveill.</a> 2024;29(45):pii=2400705. <a href="https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400705" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400705</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 24 Oct 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 07 Nov 2024 </span> </p>
/content/10.2807/1560-7917.ES.2024.29.45.2400705
/content/10.2807/1560-7917.ES.2024.29.45.2400705
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error